Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Fellowship - Priority Announcement: Gastroenterology

McMaster University

$45,000.00

The role of intestinal microbiota in the metabolism of gluten proteins: Implications for Celiac Disease and Gluten Sensitivity.

EF 2013-14

Résumé
Celiac disease (CD) is one of the most common food-sensitive disorders in humans affecting approximately 1:100 individuals, including Canada. Gluten, a common component of the human diet, causes CD. Digestive enzymes are unable to digest gluten efficiently leading to an inflammatory reaction in people who carry the celiac genes. Although celiac genes are necessary to develop CD, they are not sufficient. Only 1% of individuals with genetic predisposition and consuming gluten will develop intestinal damage. Thus, it has been speculated that additional environmental factors may be required. Several studies have reported an alteration of gut bacteria in patients with CD. However it is unclear whether the presence of abnormal bacteria is cause or consequence of the disease. I have previously identified gut bacteria that can degrade gluten in a test tube (in vitro), although the exact products of digestion remain to be determined. Thus, the central aim of the research proposed here is to determine the metabolic products and the impact of gut bacteria previously identified on the responses to gluten in animal models (in vivo) that express the human celiac gene. Currently, a strict life-long gluten-free diet is the only efficient treatment available for CD. This is both financially and socially difficult for patients. Our approach has the potential to identify safe, novel probiotic strategies for CD and patients with gluten intolerance.
Programme
Fellowship - Priority Announcement: Gastroenterology
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
302096
Name
Caminero Fernández Alberto
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The role of intestinal microbiota in the metabolism of gluten proteins: Implications for Celiac Disease and Gluten Sensitivity.
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement: Gastroenterology
Keyworddelim
Celiac Disease; Gluten Metabolism; Gluten Sensitive Mice; Gluten Sensitivity; Intestinal Inflammation; Intestinal Microbiota; Intestinal Permeability; Probiotics
Abstract
Celiac disease (CD) is one of the most common food-sensitive disorders in humans affecting approximately 1:100 individuals, including Canada. Gluten, a common component of the human diet, causes CD. Digestive enzymes are unable to digest gluten efficiently leading to an inflammatory reaction in people who carry the celiac genes. Although celiac genes are necessary to develop CD, they are not sufficient. Only 1% of individuals with genetic predisposition and consuming gluten will develop intestinal damage. Thus, it has been speculated that additional environmental factors may be required. Several studies have reported an alteration of gut bacteria in patients with CD. However it is unclear whether the presence of abnormal bacteria is cause or consequence of the disease. I have previously identified gut bacteria that can degrade gluten in a test tube (in vitro), although the exact products of digestion remain to be determined. Thus, the central aim of the research proposed here is to determine the metabolic products and the impact of gut bacteria previously identified on the responses to gluten in animal models (in vivo) that express the human celiac gene. Currently, a strict life-long gluten-free diet is the only efficient treatment available for CD. This is both financially and socially difficult for patients. Our approach has the potential to identify safe, novel probiotic strategies for CD and patients with gluten intolerance.
Competitiondate
201311
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Caminero Fernández, Alberto
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $45,000~ $0~